Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Data Monitoring Committee recommends continuation of phase III StemEx trial

Feb. 12, 2010

Gene recurrence score may be useful for prognosis in node-positive breast cancer

Feb. 12, 2010

4SC begins dosing in first-in-man phase I trial of 4SC-205 in cancer

Feb. 11, 2010

Novartis describes identification of compounds targeting PI3K

Feb. 11, 2010

Cancer Research Technology claims novel dual CYP26 inhibitors/RAMBAs

Feb. 11, 2010

The CXCR1antagonist repertaxin targets breast cancer stem cells in vivo

Feb. 11, 2010

Tamoxifen plus chemotherapy beneficial in postmenopausal breast cancer patients

Feb. 11, 2010

Progenics reports the identification of a wide range of PI3K inhibitors

Feb. 10, 2010

Denosumab superior to Zometa in prostate cancer patients with bone metastases

Feb. 10, 2010

Lilly's Gemzar approved in Japan for additional indication of breast cancer

Feb. 9, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...